Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Translating metabolomics into clinical practice

Metabolomics is on the precipice of transforming from a research tool into a powerful clinical platform to improve precision medicine. However, metabolomics methods need to be validated in clinical research to enable rapid translation of research results into clinical tests.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Proposed translational pipeline to accelerate the clinical translation of metabolomics.


  1. Kim, E. R. et al. Urine-NMR metabolomics for screening of advanced colorectal adenoma and early stage colorectal cancer. Sci. Rep. 9, 1–10 (2019).

    Google Scholar 

  2. Yang, K. et al. Metabolomics approach for predicting response to neoadjuvant chemotherapy for colorectal cancer. Metabolomics 14, 1–9 (2018).

    Article  Google Scholar 

  3. Di Donato, S. et al. A serum metabolomics classifier derived from elderly patients with metastatic colorectal cancer predicts relapse in the adjuvant setting. Cancers 13, 2762 (2021).

    Article  Google Scholar 

  4. Parksepp, M. et al. Metabolomics approach revealed robust changes in amino acid and biogenic amine signatures in patients with schizophrenia in the early course of the disease. Sci. Rep. 10, 1–11 (2020).

    Article  Google Scholar 

  5. Cui, G. et al. Salivary metabolomics reveals that metabolic alterations precede the onset of schizophrenia. J. Proteome Res. 20, 5010–5023 (2021).

    Article  Google Scholar 

  6. Yachida, S. et al. Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer. Nat. Med. 25, 968–976 (2019).

    Article  Google Scholar 

  7. Lokhov, P. G., Trifonova, O. P., Maslov, D. L., Lichtenberg, S. & Balashova, E. E. Diagnosis of Parkinson’s disease by a metabolomics-based laboratory-developed test (LDT). Diagnostics 10, 332 (2020).

    Article  Google Scholar 

  8. Liu, N. et al. Comparison of untargeted metabolomic profiling vs traditional metabolic screening to identify inborn errors of metabolism. JAMA Netw. Open 4, e2114155 (2021).

    Article  Google Scholar 

  9. Fernández-Ochoa, A. L. et al. Metabolic disturbances in urinary and plasma samples from seven different systemic autoimmune diseases detected by HPLC-ESI-QTOF-MS. J. Proteome Res. 19, 3220–3229 (2020).

    Article  Google Scholar 

  10. Buergel, T. et al. Metabolomic profiles predict individual multidisease outcomes. Nat. Med. 28, 2309–2320 (2022).

    Article  Google Scholar 

Download references


The author thanks BMBF, DLR and DFG for funding, and I. Wilson and N. Bliziotis for useful feedback on the manuscript and figure.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Jennifer A. Kirwan.

Ethics declarations

Competing interests

J.K. undertakes paid consultancy work for Centogene GmBH: the rare disease company.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kirwan, J.A. Translating metabolomics into clinical practice. Nat Rev Bioeng (2023).

Download citation

  • Published:

  • DOI:


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research